These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 360478)

  • 1. [Liver-protective substances, dietary treatment and cures in the treatment of hepatic diseases (author's transl)].
    Egger G
    Ther Umsch; 1978 Sep; 35(9):761-5. PubMed ID: 360478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of aminoacid and protein metabolism disturbances in liver disease (author's transl)].
    Gerok W
    Leber Magen Darm; 1981 Apr; 11(2):63-72. PubMed ID: 6785546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diet and liver diseases].
    Schmid M
    Ther Umsch; 1986 Oct; 43(10):739-42. PubMed ID: 3824250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diet in liver diseases in childhood?].
    Cario WR; Bunke H; Mau H
    Z Arztl Fortbild (Jena); 1987; 81(13):661-4. PubMed ID: 3687079
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral balanced synthetic diet (author's transl)].
    Hartig W
    Zentralbl Chir; 1976; 101(21):1288-95. PubMed ID: 827146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diet in liver disease (author's transl)].
    Knoblauch M
    Schweiz Rundsch Med Prax; 1974 Oct; 63(9):1166-8. PubMed ID: 4409224
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary management of liver disease.
    Bateman EC
    Proc Nutr Soc; 1979 Dec; 38(3):331-6. PubMed ID: 531026
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bed rest, diet and working capability in liver disease (author's transl)].
    Franken FH
    Leber Magen Darm; 1977 Oct; 7(5):300-5. PubMed ID: 926979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Main characteristics of the treatment of liver cirrhosis].
    Mörl M
    Ther Ggw; 1981 May; 120(5):422-41. PubMed ID: 7233355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diet therapy in acute and chronic liver diseases].
    Müller MJ
    Ther Umsch; 1995 Aug; 52(8):528-35. PubMed ID: 7676398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP
    Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diet in liver diseases--the present and past].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1986; 80(15):605-6. PubMed ID: 3776230
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basics of nutrition in cirrhosis of the liver].
    Mörk H
    MMW Fortschr Med; 2007 Apr; 149(17):33-4. PubMed ID: 17674907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
    Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatic coma and hepatic encephalopathy].
    Lelbach WK
    Med Welt; 1974 Nov; 25(46):1921-6. PubMed ID: 4456138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of a water-soluble derivative of silymarin on morphological and functional alterations of mouse hepatocytes induced by Frog Virus 3 (author's transl)].
    Gendrault JL; Steffan AM; Elharrar M; Kirn A
    Arzneimittelforschung; 1979; 29(5):786-91. PubMed ID: 582977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic sarcoidosis with portal hypertension and liver failure. Report of a case and review of the literature (author's transl)].
    Buffet C; Martin E; Imbert MC; Chousterman M; Labayle D; Etienne JP
    Gastroenterol Clin Biol; 1977; 1(8-9):671-80. PubMed ID: 913966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.